90-minute Program
Effective dates for CE credit: 9/6/2023 – 9/6/2025
Description
Diabetes Care and Education Specialists (DCESs) play a critical role in ensuring people with diabetes and chronic kidney disease (CKD) are receiving guideline-directed care and education that optimizes outcomes, safety, and quality of life. This session will provide a review of current management recommendations for people with type 2 diabetes and CKD and utilize a case scenario to highlight the role of the DCES in optimizing CKD outcomes.
Learning Outcome
Learners will explain current recommendations for the management and education of people with type 2 diabetes and chronic kidney disease.
Learning Objectives
At the end of this presentation, participants will be able to:
-- Recognize the burden of chronic kidney disease (CKD) in people with type 2 diabetes (T2D).
-- Review current guidelines and recommendations for the treatment of chronic kidney disease (CKD) in type 2 diabetes (T2D).
-- Discuss medication- and person-specific considerations for use of medications for the treatment of CKD in people with T2D.
-- Apply current recommendations for the treatment and education of people with CKD and T2D to a clinical case scenario.
Activity Type
This recording of a live presentation is a knowledge-based learning activity.
Learning Format
Enduring Material
Intended Audience
This activity is designed for individual or groups of diabetes care and education specialists, including nurses, dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners, clinical nurse specialists, physicians, PAs, social workers, and other health care providers interested in staying up to date on current practices of care for people with diabetes and other related conditions.
Joint Providership
None
Financial Support
None
Access Period
You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).
Originally presented on: 9/6/2023
Expiration date: 9/6/2025